Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Walgreens, Teva accused of fueling opioid addiction in quest for new markets
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
Teva Has Potential For 6% CAGR Ahead, UBS Says In Upgrade
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
Teva stock plummets 18% after rough quarter in US generic drug market